1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Blood Plasma Derivatives Market – by Type

1.3.2        North America Blood Plasma Derivatives Market – by Application

1.3.3        North America Blood Plasma Derivatives Market – by End User

1.3.4        North America Blood Plasma Derivatives Market – by Country

2.           North America Blood Plasma Derivatives Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Blood Plasma Derivatives Market – Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.2.1        Expert’s Opinion

5.           North America Blood Plasma Derivatives Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increase in Prevalence of Blood Disorders

5.1.2        Rise in Geriatric Population

5.2         Market Restraints

5.2.1        Complicated Reimbursement Policies

5.3         Market Opportunities

5.3.1        Incorporation of Platelet-Rich Plasma in Regenerative Medicine

5.4         Future Trends

5.4.1        Increasing Usage of Immunoglobulin G in Multiple Treatments

5.5         Impact Analysis

6.           Blood Plasma Derivatives Market – North America Analysis

6.1         North America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.           North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – by Type

7.1         Overview

7.2         North America Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)

7.3         Albumin

7.3.1        Overview

7.3.2        Albumin: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Factor VIII

7.4.1        Overview

7.4.2        Factor VIII: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Factor IX

7.5.1        Overview

7.5.2        Factor IX: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Immunoglobulin

7.6.1        Overview

7.6.2        Immunoglobulin: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.3        IgG

7.6.3.1          Overview

7.6.3.2          IgG: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.4        IgM

7.6.4.1          Overview

7.6.4.2          IgM: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.5        IgA

7.6.5.1          Overview

7.6.5.2          IgA: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.6        IgD

7.6.6.1          Overview

7.6.6.2          IgD: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.7        IgE

7.6.7.1          Overview

7.6.7.2          IgE: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.7         Hyperimmune Globulin

7.7.1        Overview

7.7.2        Hyperimmune Globulin: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.8         Others

7.8.1        Overview

7.8.2        Others: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8.           North America Blood Plasma Derivatives Market Analysis and Forecasts to 2028 – by Application

8.1         Overview

8.2         North America Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)

8.3         Hemophilia

8.3.1        Overview

8.3.2        Hemophilia: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Hypogammaglobulinemia

8.4.1        Overview

8.4.2        Hypogammaglobulinemia: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Immunodeficiency Diseases

8.5.1        Overview

8.5.2        Immunodeficiency Diseases: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Von Willebrand Disease

8.6.1        Overview

8.6.2        Von Willebrand Disease: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8.7         Other Applications

8.7.1        Overview

8.7.2        Other Applications: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

9.           North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – by End User

9.1         Overview

9.2         North America Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Clinics

9.4.1        Overview

9.4.2        Clinics: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Other End Users

9.5.1        Overview

9.5.2        Other End Users: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.        North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – Country Analysis

10.1      Overview

10.1.1     North America: Blood Plasma Derivatives Market, by Country, 2021 & 2028 (%)

10.1.1.1       US: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       US: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3       US: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.1.3.1     US: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.1.4       US: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.1.5       US Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

10.1.1.2       Canada: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       Canada: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3       Canada: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.2.3.1     Canada: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.2.4       Canada: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.2.5       Canada Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

10.1.1.3       Mexico: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       Mexico: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       Mexico: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.3.3.1     Mexico: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.3.4       Mexico: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.3.5       Mexico Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

11.        Industry Landscape

11.1      Overview

11.2      Growth Strategies in the Blood Plasma Derivatives Market

11.3      Inorganic Growth Strategies

11.3.1     Overview

11.4      Organic Growth Strategies

11.4.1     Overview

12.        Company Profiles

12.1      Grifols SA

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      SK Plasma Co Ltd

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Octapharma AG

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Monobind Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Intas Pharmaceuticals Ltd

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Takeda Pharmaceutical Co Ltd

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      CSL Behring LLC

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      LFB SA

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Kedrion SpA

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             US Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 3.             US Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 4.             US Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Canada Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Canada Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Canada Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Canada Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Mexico Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Mexico Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Mexico Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Mexico Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Recent Inorganic Growth Strategies in the Blood Plasma Derivatives Market

Table 14.          Recent Organic Growth Strategies in the Blood Plasma Derivatives Market

Table 15.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Blood Plasma Derivatives Market Segmentation

Figure 2.           North America Blood Plasma Derivatives Market, by Country

Figure 3.           North America Blood Plasma Derivatives Market Overview

Figure 4.           Immunoglobulin Segment Held Largest Share of Type Segment in North America Blood Plasma Derivatives Market

Figure 5.           US is Expected to Show Remarkable Growth During Forecast Period

Figure 6.           North America: PEST Analysis

Figure 7.           Experts’ Opinion

Figure 8.           North America Blood Plasma Derivatives Market: Impact Analysis of Drivers and Restraints

Figure 9.           North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10.        North America Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)

Figure 11.        Albumin: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Factor VIII: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Factor IX: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Immunoglobulin: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        IgG: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        IgM: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        IgA: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        IgD: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        IgE: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Hyperimmune Globulin: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Others: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        North America Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)

Figure 23.        Hemophilia: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Hypogammaglobulinemia: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Immunodeficiency Diseases: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Von Willebrand Disease: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Other Applications: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        North America Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)

Figure 29.        Hospitals: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Clinics: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Other End Users: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        North America: Blood Plasma Derivatives Market, by Key Country – Revenue (2021) (US$ Million)

Figure 33.        US: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Canada: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Mexico: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36.        Growth Strategies in the Blood Plasma Derivatives Market